Russell Investments Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $824K | Buy |
61,743
+53,489
| +648% | +$714K | ﹤0.01% | 2154 |
|
|
2025
Q1 | $84.1K | Sell |
8,254
-25,067
| -75% | -$255K | ﹤0.01% | 2794 |
|
|
2024
Q4 | $527K | Sell |
33,321
-68,995
| -67% | -$1.09M | ﹤0.01% | 2255 |
|
|
2024
Q3 | $5.94M | Buy |
102,316
+19,964
| +24% | +$1.16M | 0.01% | 1103 |
|
|
2024
Q2 | $3.76M | Hold |
82,352
| – | – | 0.01% | 1289 |
|
|
2024
Q1 | $5.45M | Sell |
82,352
-12,205
| -13% | -$808K | 0.01% | 1127 |
|
|
2023
Q4 | $3.76M | Buy |
94,557
+18,682
| +25% | +$743K | 0.01% | 1275 |
|
|
2023
Q3 | $2.42M | Buy |
75,875
+7,313
| +11% | +$233K | ﹤0.01% | 1439 |
|
|
2023
Q2 | $2.75M | Buy |
68,562
+12,976
| +23% | +$521K | 0.01% | 1381 |
|
|
2023
Q1 | $2.37M | Buy |
55,586
+14,379
| +35% | +$614K | ﹤0.01% | 1475 |
|
|
2022
Q4 | $1.98M | Buy |
41,207
+16,348
| +66% | +$785K | ﹤0.01% | 1600 |
|
|
2022
Q3 | $934K | Buy |
+24,859
| New | +$934K | ﹤0.01% | 1966 |
|